Live Breaking News & Updates on Development Ltd Hadasit

Established Exclusive Worldwide Collaboration and License Agreement with Roche and Genentech for the Development and Commercialization of RG6501 (OpRegen®) in Transaction Worth up to $670 MillionRetinal Tissue Restoration and Visual Improvements Reported in Four Patients Treated with RG6501 (OpRegen) for Dry Age-Rel. ....

United States , Mike Biega , Kevinl Cook , Brianm Culley , Dipti Amin , Anula Jayasuriya , Georgea Samuel , Cell Therapeutics Inc , Hadasit Medical Research Services , Development Ltd Hadasit , Exchange Commission , Lineage Cell Therapeutics Inc , Israel Innovation Authority , Company On Twitter Lineagecell , Roche Group , Paycheck Protection Program , Immunomic Therapeutics Inc , Established Exclusive Worldwide Collaboration , License Agreement , Transaction Worth , Tissue Restoration , Visual Improvements Reported , Four Patients Treated , Dry Age Related Macular , Clinical Testing Initiated , Support New Delivery Device ,